Track the 에스디바이오센서 share price and the full insider trade history of the company, a listed issuer based in South Korea. Shares trade on the KR market, under the authority of DART (FSS). Operating in the Health Care sector, 에스디바이오센서 has recorded 75 insider filings. Market capitalisation: €729.7bn. The latest transaction was reported on 24 March 2026 (Purchase). Among the most active insiders: 김석규. All data is openly available.
73
Insider Decl.
n/a
Thresholds
€2m
56 ops.
Buy Volume
n/a
12 ops.
Sell Volume
32Σ signal
Buys €2mn/a Sells
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Fundamental score
Ranked 20,461 of 29,053 companies
38.1
score / 100
Value
50
Quality
26
FCF yld41%
Earn yld-69%
EV/EBITDA·
ROE-27%
Gross mgn46%
Net mgn-72%
Debt/EBITDA·
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Σ
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
Listed on the XKRX market, 에스디바이오센서 is a company specializing in the health and pharmaceutical sector. It focuses on the development and manufacturing of medical diagnostic devices.